Roquefort Therapeutics- Midkine Antibody Licencing Deal

Client News Roquefort Therapeutics- Midkine Antibody Licencing Deal Home / Client News / Roquefort Therapeutics- Midkine Antibody Licencing Deal Roquefort Therapeutics plc (LSE:ROQ), the Main Market listed biotech company focused on developing first in class medicines...

Upland Resources- Resources Update

Client News Upland Resources- Resources Update Home / Client News / Upland Resources- Resources Update Upland is pleased to provide to the market further detail on preliminary resource indicators for Block SK334.   In summary, Block SK334 is an area directly adjoining...

Upland Resources- Restoration of Trading

Client News Upland Resources- Restoration of Trading Home / Client News / Upland Resources- Restoration of Trading Upland Resources Limited (LSE: UPL), is pleased to announce the lifting of the voluntary suspension and the restoration of trading in its ordinary shares...

Upland Resources- Annual Financial Report

Client News Upland Resources- Annual Financial Report Home / Client News / Upland Resources- Annual Financial Report Upland Resources Limited (LSE: UPL), is pleased to announce the publication of its audited annual report and financial statements for the 18-month...